Subjects
-Tags
-Abstract
Background: Roux-en-Y hepaticojejunostomy (RYHJ) is currently considered the definitive treatment for iatrogenic bile
duct injuries. This work aimed to assess the medical indications for HJ and analyze the postoperative complications of HJ.
Patients and Methods: This prospective observational was conducted on 33 patients who underwent HJ for various
benign diseases. The patients were divided into two groups: Patients with complications (n=19) and no complications
group (n=14).
Results: Patients with complications had a longer mean hospital stay and a higher average blood loss compared with those without complications. The logistic regression analysis identifies several variables potentially impacting the likelihood of postoperative complications, though none achieve statistical significance under the traditional P value threshold of 0.05. Age (P=0.075) and diabetes (P=0.078) approach significance, suggesting their possible influence on complication rates.
Conclusion: Our study concluded that age and diabetes demonstrate higher associations with complication rates. Chest
infections is the most common postoperative complication. In the group with complications exhibited elevated bilirubin
levels greater than 2 mg/dl.
DOI
10.21608/EJSUR.2024.286801.1063
Keywords
Benign biliary diseases, Complications, Hepaticojejunostomy, outcomes
Authors
MiddleName
-Affiliation
Department of General Surgery, Faculty of Medicine, Suez Canal University, Suez Canal, Egypt
Email
-City
-Orcid
-MiddleName
-Affiliation
Department of General Surgery, Faculty of Medicine, Suez Canal University, Suez Canal, Egypt
Email
-City
-Orcid
-MiddleName
-Affiliation
Department of General Surgery, Faculty of Medicine, Suez Canal University, Suez Canal, Egypt
Email
-City
-Orcid
-Link
https://ejsur.journals.ekb.eg/article_384107.html
Detail API
https://ejsur.journals.ekb.eg/service?article_code=384107
Publication Title
The Egyptian Journal of Surgery
Publication Link
https://ejsur.journals.ekb.eg/
MainTitle
Postoperative outcomes of hepaticojejunostomy for benign biliary diseases.